All Updates

All Updates

icon
Filter
Earnings/results
Kalera’s Q2 2022 earnings update: Losses widen despite strong top-line
Vertical Farming
Aug 19, 2022
This week:
Funding
Haber raises USD 44 million in Series C funding from Creaegis
Smart Factory
Yesterday
Geographic expansion
AML3D opens US technology center in Ohio to support defense and industrial customers
Additive Manufacturing
Yesterday
M&A
3D Systems sells Geomagic software portfolio to Hexagon for USD 123 million
Additive Manufacturing
Yesterday
Product updates
Meta launches AI model to enhance Metaverse experiences
Metaverse Platforms
Yesterday
Product updates
Noom launches oral weight loss medication program
Digital Wellness
Dec 12, 2024
Partnerships
Conduit Pharmaceuticals partners with SARBORG to integrate AI and cybernetics in drug development
AI Drug Discovery
Dec 12, 2024
Product updates
Absci selects drug candidate ABS-201 for hair loss treatment
AI Drug Discovery
Dec 12, 2024
Product updates
Evaxion develops AI-powered precision cancer vaccine concept
AI Drug Discovery
Dec 12, 2024
M&A
General Inception acquires Enable Medicine for undisclosed sum to boost AI-driven drug discovery
AI Drug Discovery
Dec 12, 2024
Partnerships
Dewpoint Therapeutics partners with ConcertAI to advance oncology drug
AI Drug Discovery
Dec 12, 2024
Vertical Farming

Vertical Farming

Aug 19, 2022

Kalera’s Q2 2022 earnings update: Losses widen despite strong top-line

Earnings/results

  • Kalera’s Q2 2022 revenue grew 160% YoY to USD 1.3 million, compared to USD 0.5 million in the same period last year. Revenue for 1H 2022 reached USD 2.8 million, growing by 250% YoY. The quarterly growth in the top line was due to the increases in retail revenue (+46% YoY) and foodservice revenue (+489% YoY) and the opening of new facilities over the past year.

  • Despite the strong topline performance, Kalera’s operating losses increased by 11.4x YoY amounting to USD 96.8 million for Q2 2022. This was primarily due to the one-time transaction expenses (USD 7.5 million) relating to the SPAC merger with Agrico and Nasdaq listing, which led to increased selling, general and administrative expenses (+311.7% YoY), one-time non-cash stock option expense (USD 8 million), and one-time non-cash expense for goodwill impairment (USD 64.3 million) during the period.

  • Adjusted EBITDA loss for the quarter worsened 120.3% YoY to USD 14.1 million, compared to the adjusted EBITDA loss of USD 6.4 million in the same period last year.

  • The company did not provide any revenue or profit guidance for the next quarter or for the full-year 2022. However, the company has outlined its growth strategy for 2022 and 2023 as follows: 

    • Planned expansion into select markets and communities that previously did not have access to local and fresh produce

    • Optimizing production capacity within the US as well as internationally across all products in its portfolio

    • Improving farm profitability and becoming cash-flow positive at all existing farms with plans to delay operations at the Hawaii, Columbus, and Central Florida facilities.

    • Expanding product portfolio and customer base (including both retail and food service)

Key milestones for Q2 2022 include:

<ul><li>Completed merger with Agrico Acquisition Corp and subsequent Nasdaq listing in June 2022 upon approval after a special shareholder meeting, trading under the new ticker symbol “KAL”.</ul>

<ul><li>Partnered with US Foods in May 2022 , resulting in 50% allocation of its production capacity to the restaurant and foodservice sector.</ul>

<ul><li>Manufacturing capacity: Opened a new 90,000 sq ft facility in Denver in April 2022 , the fifth farm in its US VF network. Completed Phase One of the Singapore facility in March 2022, with the first harvest expected to be in Q3 2022.</ul>

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.